Related Experiment Videos
Hormone-refractory prostate cancer: an evolving standard of care
E J Small1, D M Reese, N J Vogelzang
1University of California, San Francisco Comprehensive Cancer Center, 94115, USA.
Seminars in Oncology
|December 22, 1999
Abstract:
The treatment of advanced prostate cancer has evolved rapidly in the last several years. Therapeutic options for patients with advanced disease, once limited to the use of androgen deprivation, have expanded to include a number of interventions, including secondary hormonal manipulations, chemotherapy, and a variety of investigational approaches.